Super-Oxide Dismutase Mimetics
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,350,193 | Super-Oxide Dismutase Mimetics In force · High confidence UsedRemaining | Galera Labs, LLC | In force | High confidence | ||
| US 9,353,069 | Super-Oxide Dismutase Mimetics Lapsed May 31, 2024 on the fee record High confidence | Galera Labs, LLC | Lapsed May 31, 2024 on the fee record | High confidence | ||
| US 8,486,928 | Super-Oxide Dismutase Mimetics Lapsed Jul 16, 2025 on the fee record High confidence | Galera Labs, LLC | Lapsed Jul 16, 2025 on the fee record | High confidence | ||
| Application 16/509,131 | Super-Oxide Dismutase Mimetics Abandoned Abandoned Sep 15, 2020 | Galera Labs, LLC | Abandoned | Abandoned Sep 15, 2020 | ||
| Application 16/946,389 | Super-Oxide Dismutase Mimetics Abandoned Abandoned Aug 8, 2022 | Galera Labs, LLC | Abandoned | Abandoned Aug 8, 2022 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Galera Labs, LLC.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.